Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Chlorpromazine for schizophrenia: a Cochrane systematic review of 50 years of randomised controlled trials

  • Clive Elliott Adams1Email author,
  • John Rathbone1,
  • Ben Thornley1,
  • Mike Clarke2,
  • Jo Borrill3,
  • Kristian Wahlbeck4 and
  • A George Awad5
BMC Medicine20053:15

DOI: 10.1186/1741-7015-3-15

Received: 16 May 2005

Accepted: 17 October 2005

Published: 17 October 2005

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
16 May 2005 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Reviewed Reviewer Report
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
17 Oct 2005 Editorially accepted
17 Oct 2005 Article published 10.1186/1741-7015-3-15

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Cochrane Schizophrenia Group, Academic Department of Psychiatry and Behavioural Sciences, University of Leeds
(2)
UK Cochrane Centre
(3)
Safer Custody Group, HM Prison Service, Abell House
(4)
Department of Psychiatry, STAKES/Vasa Central Hospital
(5)
University of Toronto, Humber River Regional Hospital

Advertisement